Unlock stock picks and a broker-level newsfeed that powers Wall Street.
BSE - Delayed Quote INR

RPG Life Sciences Limited (RPGLIFE.BO)

Compare
2,181.75
-130.25
(-5.63%)
At close: April 4 at 3:24:09 PM GMT+5:30
Loading Chart for RPGLIFE.BO
  • Previous Close 2,312.00
  • Open 2,305.55
  • Bid 2,163.80 x --
  • Ask 2,184.80 x --
  • Day's Range 2,143.45 - 2,310.60
  • 52 Week Range 1,382.55 - 2,976.70
  • Volume 674
  • Avg. Volume 1,374
  • Market Cap (intraday) 36.084B
  • Beta (5Y Monthly) 0.01
  • PE Ratio (TTM) 45.66
  • EPS (TTM) 47.78
  • Earnings Date Apr 28, 2025 - May 2, 2025
  • Forward Dividend & Yield 16.00 (0.73%)
  • Ex-Dividend Date Jun 28, 2024
  • 1y Target Est --

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, and anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and finished dosage formulations for various therapies, which include nephrology, rheumatology, oncology, gastroenterology, cardiology, orthopedics, nutritional, diabetology, respiratory, neuropsychiatry, urology, vitamins and minerals, gastrointestinal, pain management, anti-diabetic, gynecology, cardiovascular, pediatrics, neurology, anti-dengue, and dermatology, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.

www.rpglifesciences.com

1,270

Full Time Employees

March 31

Fiscal Year Ends

Recent News: RPGLIFE.BO

View More

Performance Overview: RPGLIFE.BO

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

RPGLIFE.BO
0.21%
S&P BSE SENSEX (^BSESN)
3.55%

1-Year Return

RPGLIFE.BO
41.57%
S&P BSE SENSEX (^BSESN)
1.53%

3-Year Return

RPGLIFE.BO
288.73%
S&P BSE SENSEX (^BSESN)
24.34%

5-Year Return

RPGLIFE.BO
1,190.62%
S&P BSE SENSEX (^BSESN)
173.15%

Compare To: RPGLIFE.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RPGLIFE.BO

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    35.99B

  • Enterprise Value

    34.73B

  • Trailing P/E

    45.60

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.70

  • Price/Book (mrq)

    9.51

  • Enterprise Value/Revenue

    5.49

  • Enterprise Value/EBITDA

    25.38

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    12.42%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    6.37B

  • Net Income Avi to Common (ttm)

    791.3M

  • Diluted EPS (ttm)

    47.78

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.26B

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: RPGLIFE.BO

View More

Company Insights: RPGLIFE.BO

Research Reports: RPGLIFE.BO

View More

People Also Watch